Kathmere Capital Management’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-577	Closed	-$241K	–	360
2024 Q1	$241K	Buy	577 +52	+10%	+$21.7K	0.03%	273
2023 Q4	$214K	Buy	+525	New	+$214K	0.03%	264
2021 Q1	–	Sell	-100	Closed	-$24K	–	402
2020 Q4	$24K	Buy	+100	New	+$24K	0.01%	279